GDTC – cytomed therapeutics limited - ordinary shares (US:NASDAQ)
Stock Stats
News
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy
CytoMed Therapeutics’ Chairman Increases Effective Holdings to 21.95%
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
Form 6-K CytoMed Therapeutics For: Nov 18
Form 6-K CytoMed Therapeutics For: Nov 06
Form SCHEDULE 13D/A CytoMed Therapeutics Filed by: Choo Chee Kong
Form 6-K CytoMed Therapeutics For: Oct 22
Form 6-K CytoMed Therapeutics For: Oct 14
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.